Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption

Bone

Volumn 44, Issue 6, 2009, Pages 1169-1176

  Ozaki, Yukio ^a   Ukai, Takashi ^a   Yamaguchi, Masayuki ^a   Yokoyama, Miho ^a   Ayón Haro, Esperanza R ^a   Yoshimoto, Mayumi ^a   Kaneko, Takashi ^a   Yoshinaga, Miho ^a   Nakamura, Hirotaka ^a   Shiraishi, Chiaki ^a   Hara, Yoshitaka ^a  

^a Unit of Translational Medicine   (Japan)

Author keywords

Bone resorption; Lipopolysaccharide; Osteoclast; T cell; Tumor necrosis factor

Indexed keywords

LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; IMMUNIZATION; IMMUNOHISTOLOGY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; BONE RESORPTION; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, SCID; OSTEOCLASTS; RANK LIGAND; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349147067     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.01.375     Document Type: Article

References (46)

1. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20 (1999) 345-357
2. Weitzmann M.N., Cenci S., Rifas L., Haug J., Dipersio J., and Pacifici R. T cell activation induces human osteoclast formation via receptor activator of nuclear factor κB ligand-dependent and -independent mechanisms. J. Bone Miner. Res. 16 (2001) 328-337
3. Quinn J.M., Elliott J., Gillespie M.T., and Martin T.J. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology. 139 (1998) 4424-4427
4. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
5. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139 (1998) 1329-1337
6. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-285
7. Kim N., Kadono Y., Takami M., Lee J., Lee S.H., Okada F., et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202 (2005) 589-595
8. Teng Y.T., Nguyen H., Gao X., Kong Y.Y., Gorczynski R.M., Shigh B., et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J. Clin. Invest. 106 (2000) R59-R67
9. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
10. Alayan J., Ivanovski S., and Farah C.S. Alveolar bone loss in T helper 1/T helper 2 cytokine-deficient mice. J. Periodontal Res. 42 (2007) 97-103
11. Kawai T., Matsuyama T., Hosokawa Y., et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169 (2006) 987-998
12. Yamaguchi M., Ukai T., Kaneko T., Yoshinaga M., Yokoyama M., Ozaki Y., and Hara Y. T cells are able to promote LPS-induced bone resorption under the condition of absence of B cells in mice. J Periodont Res 43 (2008) 549-555
13. Ukai T., Hara Y., and Kato I. Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J. Periodontal Res. 31 (1996) 414-422
14. Dai S.M., Nishioka K., and Yudoh K. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumor necrosis factor α. Ann. Rheum. Dis. 63 (2004) 1379-1386
15. Kotake S., Nanke Y., Mogi M., Kawamoto M., Furuya T., Yago T., et al. IFN-γ-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur. J. Immunol. 35 (2005) 3353-3363
16. Kanamaru F., Iwai H., Ikeda T., Nakajima A., Ishikawa I., and Azuma M. Expression of membrane-bound and soluble receptor activator of NF-kB ligand (RANKL) in human T cells. Immunol. Lett. 94 (2004) 239-246
17. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J. Clin. Invest. 106 (2000) 1229-1237
18. Shinoda K., Sugiyama E., Taki H., Harada S., Mino T., Maruyama M., et al. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes. Bone 33 (2003) 711-720
19. Gao Y., Grassi F., Ryan M.R., Terauchi M., Page K., Yang X., et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117 (2007) 122-132
20. Wyzga N., Varghese S., Wikel S., Canalis E., and Sylvester F.A. Effects of activated T cells on osteoclastogenesis dependent on how they are activated. Bone 35 (2004) 614-620
21. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci. Prog. 78 (1995) 19-34
22. Takami M., Kim N., Rho J., and Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169 (2002) 1516-1523
23. Suda K., Woo J.T., Takami M., Sexton P.M., and Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J. Cell. Physiol. 190 (2002) 101-108
24. Kaisho T., and Akira S. Critical roles of Toll-like receptors in host defense. Crit. Rev., Immunol. 20 (2000) 393-405
25. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., and Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J. Immunol. 178 (2007) 7779-7786
26. Kozuka Y., Ozaki Y., Ukai T., Kaneko T., and Hara Y. B cells play an important role in lipopolysaccharide-induced bone resorption. Calcif. Tissue Int. 78 (2006) 125-132
27. Kaisho T., Hoshino K., Iwabe T., Takeuchi O., Yasui T., and Akira S. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 14 (2002) 695-700
28. Kamon H., Kawabe T., Kitamura H., Lee J., Kamimura D., Kaisho T., et al. TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation. EMBO J. 25 (2006) 4108-4119
29. Ogawa Y., Ohtsuki M., Uzuki M., Sawai T., Onozawa Y., Nakayama J., et al. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+T cells. Arthritis Rheum. 48 (2003) 3350-3358
30. Sato Y., Mukai K., Watanabe S., Goto M., and Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am. J. Pathol. 125 (1986) 431-435
31. Moriyama H., Ukai T., and Hara Y. Interferon-gamma production changes in parallel with bacterial lipopolysaccharide induced bone resorption in mice: an immunohistometrical study. Calcif. Tissue Int. 71 (2002) 53-58
32. Ukai T., Yumoto H., Gibson F.C.I.I.I., and Genco C.A. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect. Immun. 76 (2008) 812-819
33. Arron J.R., and Choi Y. Osteoimmunology: bone versus immune system. Nature 408 6812 (2000) 535-536
34. Theill L.E., Boyle W.J., and Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20 (2002) 795-823
35. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83 (2005) 170-179
36. Taubman M.A., Valverde P., Han X., and Kawai T. Immune response: the key to bone resorption in periodontal disease. J. Periodontol. 76 11-s (2005) 2033-2041
37. Hayashi S., Yamada T., Tsuneto M., Yamane T., Takahashi M., Shultz L.D., et al. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J. Immunol. 171 (2003) 5130-5139
38. Horwood N.J., Kartsogiannis V., Quinn J.M.W., Romas E., Martin T.J., and Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 265 (1999) 144-150
39. Abu-Amer Y., Ross F.P., Edwards J., and Teitelbaum S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100 (1997) 1557-1565
40. Abu-Amer Y., Erdmann J., Alexopoulou L., Kollias G., Ross F.P., and Teitelbaum S.L. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 275 (2000) 27307-27310
41. Itonaga I., Sabokbar A., Murray D.W., and Athanasou N.A. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann. Rheum. Dis. 59 (2000) 26-31
42. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 6882 (2002) 744-749
43. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408 6812 (2000) 600-605
44. Mirosavljevic D., Quinn J.M., Elliott J., Horwood N.J., Martin T.J., and Gillespie M.T. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis. J. Bone Miner. Res. 18 6 (2003) 984-993
45. Huang W., O'Keefe R.J., and Schwarz E.M. Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res. Ther. 5 (2003) R49-R59
46. Lee Y., Hyung S.W., Jung H.J., Kim H.J., Staerk J., Constantinescu S.N., et al. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood 111 2 (2008) 885-893